About Complement factor H-related protein 2
Complement factor H-related protein 2 (CFHR2) is a protein
from Homo sapiens identified by UniProt accession
P36980, 270 residues long.
MolForge cross-references it against 0 known binders and
69 disease associations.
Target properties
| Protein name | Complement factor H-related protein 2 |
| UniProt accession | P36980 |
| Gene | CFHR2 |
| Organism | Homo sapiens |
| Length | 270 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (69)
Diseases linked to this target (Open Targets).
- non-immunoglobulin-mediated membranoproliferative glomerulonephritis · score 0.46
- complement factor H-related protein 2 measurement · score 0.42
- age-related macular degeneration · score 0.41
- sex hormone-binding globulin measurement · score 0.33
- blood protein measurement · score 0.30
- coagulation factor measurement · score 0.26
- complement factor H-related protein 3 measurement · score 0.25
- systolic blood pressure · score 0.24
- high density lipoprotein cholesterol measurement · score 0.23
- mean arterial pressure · score 0.22
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P36980-F1 | alphafold | PREDICTED | 90.65 | — |
Amino-acid sequence (270 residues)
MWLLVSVILI SRISSVGGEA MFCDFPKINH GILYDEEKYK PFSQVPTGEV FYYSCEYNFV SPSKSFWTRI TCAEEGWSPT PKCLRLCFFP FVENGHSESS GQTHLEGDTV QIICNTGYRL QNNENNISCV ERGWSTPPKC RSTISAEKCG PPPPIDNGDI TSFLLSVYAP GSSVEYQCQN LYQLEGNNQI TCRNGQWSEP PKCLDPCVIS QEIMEKYNIK LKWTNQQKLY SRTGDIVEFV CKSGYHPTKS HSFRAMCQNG KLVYPSCEEK
Explore Complement factor H-related protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets